Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$819M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$550M |
| 3 |
Boston Scientific
BSX
|
+$303M |
| 4 |
ExxonMobil
XOM
|
+$291M |
| 5 |
Advanced Micro Devices
AMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$513M |
| 2 |
Apple
AAPL
|
+$396M |
| 3 |
Target
TGT
|
+$379M |
| 4 |
Eli Lilly
LLY
|
+$351M |
| 5 |
EOG Resources
EOG
|
+$351M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.82% |
| 2 | Healthcare | 12.74% |
| 3 | Financials | 11.16% |
| 4 | Industrials | 8.55% |
| 5 | Consumer Discretionary | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHS
2626
DELISTED
Chicos FAS, Inc.
CHS
| $2.67M | ﹤0.01% |
537,165
+11,418
| +2% | +$57.7K |
|
2627
WisdomTree
WT
$2.96B
| $2.67M | ﹤0.01% |
525,934
-91,774
| -15% | -$526K |
|
2628
Outset Medical
OM
$84.7M
| $2.66M | ﹤0.01% |
11,935
+3,874
| +48% | +$1.67M |
|
2629
Axogen
AXGN
$2.27B
| $2.66M | ﹤0.01% |
324,572
+61,391
| +23% | +$525K |
|
2630
iShares MSCI Peru and Global Exposure ETF
EPU
$537M
| $2.66M | ﹤0.01% |
104,272
-15,954
| -13% | -$494K |
|
|
GPMT
2631
Granite Point Mortgage Trust
GPMT
$69M
| $2.65M | ﹤0.01% |
276,777
-17,422
| -6% | -$178K |
|
2632
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$741M
| $2.65M | ﹤0.01% |
77,746
-10,452
| -12% | -$367K |
|
2633
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
| $2.65M | ﹤0.01% |
29,855
-545,294
| -95% | -$50.4M |
|
|
ONL
2634
Orion Office REIT
ONL
$150M
| $2.64M | ﹤0.01% |
241,299
-10,455
| -4% | -$135K |
|
2635
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.24B
| $2.63M | ﹤0.01% |
54,596
+16,620
| +44% | +$817K |
|
2636
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$389M
| $2.63M | ﹤0.01% |
53,265
+3,532
| +7% | +$185K |
|
2637
8x8 Inc
EGHT
$269M
| $2.63M | ﹤0.01% |
511,257
+11,755
| +2% | +$98.4K |
|
2638
iShares US Telecommunications ETF
IYZ
$1.2B
| $2.63M | ﹤0.01% |
104,681
+10,656
| +11% | +$288K |
|
2639
Huron Consulting
HURN
$2.41B
| $2.63M | ﹤0.01% |
40,438
+5,059
| +14% | +$286K |
|
2640
BioCryst Pharmaceuticals
BCRX
$2.28B
| $2.63M | ﹤0.01% |
248,283
+114,055
| +85% | +$1.18M |
|
2641
Sabre
SABR
$731M
| $2.62M | ﹤0.01% |
448,949
-17,306
| -4% | -$145K |
|
2642
Kosmos Energy
KOS
$1.6B
| $2.62M | ﹤0.01% |
422,358
+124,272
| +42% | +$897K |
|
2643
Oppenheimer Holdings
OPY
$1.14B
| $2.61M | ﹤0.01% |
79,055
-2,589
| -3% | -$88.9K |
|
|
DOOR
2644
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $2.6M | ﹤0.01% |
33,906
-191,456
| -85% | -$15.7M |
|
2645
10x Genomics
TXG
$6B
| $2.6M | ﹤0.01% |
57,514
-1,578,382
| -96% | -$81.9M |
|
2646
Educational Development Corp
EDUC
$11.8M
| $2.6M | ﹤0.01% |
616,843
-16,145
| -3% | -$90.1K |
|
|
ERC
2647
Allspring Multi-Sector Income Fund
ERC
$256M
| $2.6M | ﹤0.01% |
271,922
-1,719
| -0.6% | -$16.7K |
|
2648
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
$4.06B
| $2.6M | ﹤0.01% |
104,243
+3,600
| +4% | +$91.2K |
|
2649
ENI
E
$80.5B
| $2.6M | ﹤0.01% |
109,126
-2,549
| -2% | -$72.7K |
|
2650
PDF Solutions
PDFS
$1.93B
| $2.6M | ﹤0.01% |
120,658
-961
| -0.8% | -$22.2K |
|
Similar funds
Ameriprise's Q2 2022 Portfolio in Review
As of Q2 2022, Ameriprise held 4,071 positions worth $287B, down 15% from $339B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Ameriprise's Q2 2022 filing shows 137 new, 1,635 increased, 1,970 reduced and 191 closed positions. Its largest new stake was Aspen Technology Inc: 409,068 shares worth $75.1M. The largest sale was Medtronic, an estimated $513M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2022 buy was Aspen Technology Inc: 409,068 shares worth $75.1M.
- Ameriprise added most to Wells Fargo in Q2 2022, an estimated $819M increase.
- Ameriprise's biggest Q2 2022 reduction was Medtronic, cutting an estimated $513M.
- Ameriprise fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $250M.
- Ameriprise's ten largest holdings make up 14% of its $287B portfolio in Q2 2022.
- Ameriprise opened 137 new positions and closed 191 in Q2 2022.
- Ameriprise's portfolio value fell 15% quarter-over-quarter to $287B.
Based on Ameriprise's 13F filing for Q2 2022, filed 15 Aug 2022.